The concept of innovative drugs continues to be active, CISEN once again hits the daily limit
The concept of innovative drugs continues to be active, CISEN once again hit the daily limit, ZHONGSHENGYAOYE also hit the daily limit, EASTON BIOPHARMACEUTICALS, Asia-Pacific Pharmaceutical, and Sanyuan Gene are among the top gainers
